内皮血管细胞黏附分子1是高危颈动脉斑块的标志物及超声分子成像靶点
研究前瞻性获取30例无症状与30例有症状患者颈动脉内膜剥脱术标本,用半定量免疫组化评估VCAM-1等内皮炎症标志物表达,并将靶向配体偶联至脂质微泡超声造影剂,在流动腔中评估高剪切条件下的结合。结果显示有症状患者斑块内皮VCAM-1表达为无症状者的2.4倍(P < .01),其他标志物组间无显著差异;VCAM-1靶向微泡可在高剪切条件下结合表达VCAM-1的细胞。
要点
- 有症状患者颈动脉斑块内皮VCAM-1表达为无症状者的2.4倍(P < .01)。
- P-选择素(P = .43)、血管性血友病因子(P = .59)、凝集素样氧化低密度脂蛋白受体1(P = .99)组间无显著差异。
- 约五分之一无症状患者斑块VCAM-1高表达,与有症状患者斑块相似。
核心结论
- VCAM-1在高危(有症状)较低危(无症状)颈动脉斑块上表达显著更高,携带VCAM-1配体的超声造影剂可维持高剪切附着,可能有助于识别需要更积极治疗的患者。
研究设计与样本
- 前瞻性获取人颈动脉内膜剥脱术标本,来自无症状患者30例与有症状患者30例;用半定量免疫组化评估斑块VCAM-1、凝集素样氧化低密度脂蛋白受体1、P-选择素和血管性血友病因子表达。
- 合成针对上述各靶点的小肽配体并共价偶联至脂质外壳微泡超声造影剂表面,在流动腔中评估其在不同剪切条件下与活化人主动脉内皮细胞的结合动力学。
主要发现
- 有症状患者颈动脉内膜剥脱术标本内皮VCAM-1表达为无症状患者的2.4倍(P < .01)。
- P-选择素组间表达无显著差异(P = .43),血管性血友病因子组间无显著差异(P = .59),凝集素样氧化低密度脂蛋白受体1组间无显著差异(P = .99)。
- 多数无症状患者斑块VCAM-1表达低,但约五分之一表达高VCAM-1,与有症状患者斑块相似。
- 体外流动腔实验显示VCAM-1靶向微泡可在接近人颈动脉的高剪切条件下结合表达VCAM-1的细胞,其他造影剂的结合效率较低。
关键数值与推荐
- 有症状患者较无症状患者颈动脉斑块内皮VCAM-1表达为2.4倍(P < .01)。
- P-选择素组间比较P = .43,血管性血友病因子组间比较P = .59,凝集素样氧化低密度脂蛋白受体1组间比较P = .99。
临床怎么用
- 作者认为携带VCAM-1配体的超声造影剂可维持高剪切附着,可能有助于识别需要更积极治疗的患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Molecular imaging of carotid plaque vulnerability to atheroembolic events is likely to lead to improvements in selection of patients for carotid endarterectomy (CEA). The aims of this study were to assess the relative value of endothelial inflammatory markers for this application and to develop molecular ultrasound contrast agents for their imaging. METHODS: Human CEA specimens were obtained prospectively from asymptomatic (30) and symptomatic (30) patients. Plaques were assessed by semiquantitative immunohistochemistry for vascular cell adhesion molecule 1 (VCAM-1), lectin-like oxidized low-density lipoprotein receptor 1, P-selectin, and von Willebrand factor. Established small peptide ligands to each of these targets were then synthesized and covalently conjugated to the surface of lipid-shelled microbubble ultrasound contrast agents, which were then evaluated in a flow chamber for binding kinetics to activated human aortic endothelial cells under variable shear conditions. RESULTS: Expression of VCAM-1 on the endothelium of CEA specimens from symptomatic patients was 2.4-fold greater than that from asymptomatic patients (P < .01). Expression was not significantly different between groups for P-selectin (P = .43), von Willebrand factor (P = .59), or lectin-like oxidized low-density lipoprotein receptor 1 (P = .99). Although most plaques from asymptomatic patients displayed low VCAM-1 expression, approximately one in five expressed high VCAM-1 similar to plaques from symptomatic patients. In vitro flow chamber experiments demonstrated that VCAM-1-targeted microbubbles bind cells that express VCAM-1, even under high-shear conditions that approximate those found in human carotid arteries, whereas binding efficiency was lower for the other agents. CONCLUSIONS: VCAM-1 displays significantly higher expression on high-risk (symptomatic) vs low-risk (asymptomatic) carotid plaques. Ultrasound contrast agents bearing ligands for VCAM-1 can sustain high-shear attachment and may be useful for identifying patients in whom more aggressive treatment is warranted.
引用
- Weinkauf CC, Concha-Moore K, Lindner JR, et al. Endothelial vascular cell adhesion molecule 1 is a marker for high-risk carotid plaques and target for ultrasound molecular imaging. J Vasc Surg. 2018. PMID: 29452833. doi:10.1016/j.jvs.2017.10.088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。